CirculoGene specializes in the fields of cfDNA, liquid biopsy, tumor monitoring, laboratory testing, and molecular diagnostics.
CirculoGene Theranostics has raised $2.0M in total funding. The most recent round was Debt Financing. The last funding was announced in March 2023.
CirculoGene Theranostics is headquartered in Birmingham, United States.
CirculoGene specializes in the fields of cfDNA, liquid biopsy, tumor monitoring, laboratory testing, and molecular diagnostics.
CirculoGene Theranostics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CirculoGene Theranostics — Funding & Investors." VCBacked, March 24, 2023, https://www.vcbacked.co/company/circulogene-theranostics. Accessed August 14, 2026.
VCBacked. (2023). CirculoGene Theranostics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/circulogene-theranostics
{{cite web |title=CirculoGene Theranostics — Funding & Investors |url=https://www.vcbacked.co/company/circulogene-theranostics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated